When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

Rocky Mountain MS Clinic opened a location in Lehi this week, filling a gap in care for patients who have traveled hours or ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The rising prevalence of multiple sclerosis (MS) is ...

Discover how the brain "eats" itself during a marathon, and how the recovery process opens doors to possible MS treatments.

A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.

Susan Blackborough was just 12 when she was diagnosed with multiple sclerosis and was told she would lose her ability to walk ...